﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Pharmaceutical Sciences</JournalTitle>
      <Issn>1735-403X</Issn>
      <Volume>28</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2022</Year>
        <Month>04</Month>
        <DAY>10</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Anti-proliferative and Apoptotic Effect of Tetrahydrobenzo[h]quinoline on MCF-7 Human Breast Cancer Cell</ArticleTitle>
    <FirstPage>304</FirstPage>
    <LastPage>313</LastPage>
    <ELocationID EIdType="doi">10.34172/PS.2021.58</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Ghaffari</LastName>
      </Author>
      <Author>
        <FirstName>Dariush</FirstName>
        <LastName>Shanehbandi</LastName>
      </Author>
      <Author>
        <FirstName>Solmaz</FirstName>
        <LastName>Sarhadi</LastName>
      </Author>
      <Author>
        <FirstName>Mina</FirstName>
        <LastName>Hanifeh Ahagh</LastName>
      </Author>
      <Author>
        <FirstName>Mahsa</FirstName>
        <LastName>Maleki Moghaddam</LastName>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Dehghan</LastName>
      </Author>
      <Author>
        <FirstName>Razieh</FirstName>
        <LastName>Ghodsi</LastName>
      </Author>
      <Author>
        <FirstName>Jafar</FirstName>
        <LastName>Ezzati Nazhad Dolatabadi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7434-5541</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/PS.2021.58</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>01</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>09</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <Abstract>Background: Quinoline and its derivatives display various biological activities based on versatility in designing a new drug class for medicinal applications. Hence, synthesizing innovative and varied derivatives of quinoline has gained considerable attention among chemists and biologists. This study evaluated the anti-proliferative and apoptotic effect of tetrahydrobenzo[h]quinolineon Michigan Cancer Foundation-7 (MCF-7) human breast cancer cells. Methods: The anti-proliferative effect of tetrahydrobenzo[h]quinoline was studied via MTT[3 0-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] assays. A quantitative and qualitative study of apoptosis was carried out via flow cytometry and terminal deoxynucleotidyltransferase dUTP nick end labeling (TUNEL). Quantitative real-time PCR (qPCR) and immunoblotting analysis were employed to identify the expression level of genes and proteins involved in the apoptosis signaling pathway. Results: The synthesized compound reduced 50% of cell growth at concentrations of 10 and7.5 μM during 24 and 48h, respectively, and induced apoptosis up to 30% in MCF-7 cancer cells. Regarding the gene expression level, Bcl-2 displayed considerable alleviation, whereas Bax expression increased significantly. Despite the remarkable increase in caspase 9 expression, there was no noticeable difference in the caspase 8 expression in treated cells compared to the control group. Western blotting data showed that the protein expression level of Bcl-2, pro-caspase 8, and 9 reduced. The protein content of Bax, cleaved-caspase 8, and 9 increased significantly, of which the protein level of cleaved-caspase 9 exhibited a tremendous rise in the treated group. Conclusion: The newly synthesized tetrahydrobenzo[h]quinoline can be a promising organic compound for cancer treatment if its anti-cancer effect investigates by other types of breast cancer cells. In vivo studies should be used to investigate the anti-cancer efficiency of this compound.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Quinoline</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MCF-7</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Breast cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">PCR</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cytotoxicity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Apoptosis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>